findmyKOL

Douglas Atchison, MD

Basic profile

Henry Ford Hospital

ORCIDNPI
RegionAnn Arbor, MI · MidwestSpecialtyNephrologyFocusNephrology
Active KOLfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2025Online presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Douglas Atchison is a Nephrology physician affiliated with Henry Ford Hospital. OpenAlex indexes 20 publications with 283 citations (h-index 8).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
20publications

Distinct works indexed by OpenAlex, matched via ORCID.

283citations

Total citations across indexed works.

8h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
2companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

1500 E Medical Center Dr
Ann Arbor, MI 481095000

Telephone

734-936-4000

Registry record last updated 3 Jul 2019.

View the NPPES registry record

Industry payments

2 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

View the CMS Open Payments record ↗

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cardiovascular

    60%
    Beta blocker13.2%
    Carvedilol78%Labetalol Hcl23%
    Part D<11 patients
    Angiotensin receptor blocker (ARB)12.5%
    Losartan Potassium100%
    Part D29 patients

    + 5 more classes in this area

  • Metabolism & gastrointestinal

    26.4%
    SGLT2 inhibitor16.5%
    Jardiance54%Farxiga46%
    Part D<11 patients
    GLP-1 receptor agonist3.5%
    Ozempic100%
    Part D<11 patients

    + 2 more classes in this area

  • Blood & clotting

    9.9%
    Solutions for parenteral nutrition9.9%
    Calcium Acetate100%
    Part D18 patients
Where care is delivered (Part B)100% facility · 0% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”